Online Coaching - IP Strategy Support is underway!
Are you a Pharma/Medtech Companion Diagnostic SME or a company with Diagnostic products? Are you in need of IP strategy insights or do you have questions concerning patent protection and enforcement for your products?
Join our IP program NOW. The kick-off is free of charge.
The experts of NLO – European Patent and Trademark Attorneys are available to you for a dedicated one-on-one conversation of 30 minutes online. Feel invited to benefit from this opportunity and get guidance by IP- and companion diagnostic / molecular diagnostics experts Aleksandra Zwolinska, PhD, & Barend Bouma, PhD.
These meetings will take place on demand. Are you interested? Please let us know at your earliest convenience. (Of course, a conflict check is part of the assessment for establishing a business relationship). There are only three places for free! Supported by the Codex4SME’s program.
How to apply for services?
Check your eligibility:
Does your company meets the SME definition of the EU?
Did your SME receive more than a total of €200.000 of de Minimis state aid between 2020 and 2022? For more information about de-minimis aid. You can find helpful information via these links de minimis rule and state aid.
Before you apply, read the full Business Growth Programme description
Complete application form
Submit your application and your de minimis self-declaration
Should you require any further information, please contact Lonneke Baas email@example.com and Marieke Huis in 't Veld firstname.lastname@example.org.
Note: The online training is limited to three SMEs. The selection is made on a first-come, first-served basis.
More information: The online coaching is part of the Interreg NWE-funded Codex4SMEs project. Since 2017, Codex4SMEs has built a large European network in the field of diagnostics and personalized medicine. More than 300 small and medium-sized enterprises have so far benefited from the opportunities offered. These include various events and tailored services that support SMEs in the development of innovative diagnostics.